SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NKTR Drug delivery Company -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (221)5/18/2007 9:09:42 PM
From: david nordic  Read Replies (1) | Respond to of 507
 
Mircera approval based on labeling.

Next hurdle is patent case.
What make mircera so good is long acting
Anranesp is intermediate acting
Epogen/Procrit is short acting.

AMGN to react negatively on Monday.